Health in Slovenia

Last updated
Life expectancy at birth in Slovenia Life expectancy by WBG -Slovenia.png
Life expectancy at birth in Slovenia

A new measure of expected human capital calculated for 195 countries from 1990 to 2016 and defined for each birth cohort as the expected years lived from age 20 to 64 years and adjusted for educational attainment, learning or education quality, and functional health status was published by The Lancet in September 2018. Slovenia had the twenty-fourth highest level of expected human capital with 23 health, education, and learning-adjusted expected years lived between age 20 and 64 years. [1]

Contents

Vaccination

According to a 2011 publication in CMAJ : [2] Slovenia has one of the world's most aggressive and comprehensive vaccination programs. Its program is mandatory for nine designated diseases. Within the first three months of life, infants must be vaccinated for tuberculosis, tetanus, polio, pertussis, and Haemophilus influenza type B. Within 18 months, vaccines are required for measles, mumps and rubella, and finally, before a child starts school, the child must be vaccinated for hepatitis B. While a medical exemption request can be submitted to a committee, such an application for reasons of religion or conscience would not be acceptable. Failure to comply results in a fine and compliance rates top 95%, Kraigher says, adding that for nonmandatory vaccines, such as the one for human papilloma virus, coverage is below 50%.

Mandatory vaccination against measles was introduced in 1968 and since 1978, all children receive two doses of vaccine with a compliance rate of more than 95%. [3] For TBE, the vaccination rate in 2007 was estimated to be 12.4% of the general population in 2007. For comparison, in neighboring Austria, 87% of the population is vaccinated against TBE. [4]

Obesity

It had the third highest rate of obesity in Europe in 2015. 27% of the adult population had a body mass index of 30 or more. [5]

See also:

Related Research Articles

<span class="mw-page-title-main">Vaccination</span> Administration of a vaccine to protect against disease

Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a weakened, live or killed state, or proteins or toxins from the organism. In stimulating the body's adaptive immunity, they help prevent sickness from an infectious disease. When a sufficiently large percentage of a population has been vaccinated, herd immunity results. Herd immunity protects those who may be immunocompromised and cannot get a vaccine because even a weakened version would harm them. The effectiveness of vaccination has been widely studied and verified. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the elimination of diseases such as polio and tetanus from much of the world. However, some diseases, such as measles outbreaks in America, have seen rising cases due to relatively low vaccination rates in the 2010s – attributed, in part, to vaccine hesitancy. According to the World Health Organization, vaccination prevents 3.5–5 million deaths per year.

<span class="mw-page-title-main">Vaccine</span> Pathogen-derived preparation that provides acquired immunity to an infectious disease

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future.

<span class="mw-page-title-main">Measles</span> Viral disease affecting humans

Measles is a highly contagious infectious disease caused by measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik's spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Common complications include diarrhea, middle ear infection (7%), and pneumonia (6%). These occur in part due to measles-induced immunosuppression. Less commonly seizures, blindness, or inflammation of the brain may occur. Other names include morbilli, rubeola, red measles, and English measles. Both rubella, also known as German measles, and roseola are different diseases caused by unrelated viruses.

<span class="mw-page-title-main">Vaccine hesitancy</span> Reluctance or refusal to be vaccinated or have ones children vaccinated

Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers refusals to vaccinate, delaying vaccines, accepting vaccines but remaining uncertain about their use, or using certain vaccines but not others. The scientific consensus that vaccines are generally safe and effective is overwhelming. Vaccine hesitancy often results in disease outbreaks and deaths from vaccine-preventable diseases. Therefore, the World Health Organization characterizes vaccine hesitancy as one of the top ten global health threats.

<span class="mw-page-title-main">Tick-borne encephalitis</span> Medical condition

Tick-borne encephalitis (TBE) is a viral infectious disease involving the central nervous system. The disease most often manifests as meningitis, encephalitis or meningoencephalitis. Myelitis and spinal paralysis also occurs. In about one third of cases sequelae, predominantly cognitive dysfunction, persist for a year or more.

A vaccination policy is a health policy adopted in order to prevent the spread of infectious disease. These policies are generally put into place by State or local governments, but may also be set by private facilities, such as workplaces or schools. Many policies have been developed and implemented since vaccines were first made widely available.

<span class="mw-page-title-main">Health in the Republic of Ireland</span>

Indicators of overall population health in the Republic of Ireland include risk factors such as smoking, alcohol consumption and obesity; each of which tend towards rates higher than the OECD average.

<span class="mw-page-title-main">Health in South Korea</span> Overview of health in South Korea

Life expectancy has been rising rapidly and South Korea ranked 3rd in the world for life expectancy. South Korea has among the lowest HIV/AIDS adult prevalence rate in the world, with just 0.1% of the population being infected, significantly lower than the U.S. at 0.6%, France's 0.4%, and the UK's 0.3% prevalence rate. South Korea has a good influenza vaccination rate, with a total of 43.5% of the population being vaccinated in 2019. A new measure of expected human capital calculated for 195 countries from 1920 to 2016 and defined for each birth cohort as the expected years lived from age 20 to 64 years and adjusted for educational attainment, learning or education quality, and functional health status was published by the Lancet in September 2018. South Korea had the sixth highest level of expected human capital with 26 health, education, and learning-adjusted expected years lived between age 20 and 64 years.

<span class="mw-page-title-main">Health in the Netherlands</span>

A new measure of expected human capital calculated for 195 countries from 1990 to 2016 and defined for each birth cohort as the expected years lived from age 20 to 64 years and adjusted for educational attainment, learning or education quality, and functional health status was published by the Lancet in September 2018. The Netherlands had the fourth highest level of expected human capital with 27 health, education, and learning-adjusted expected years lived between age 20 and 64 years.

<span class="mw-page-title-main">Health in Finland</span> Overview of health in Finland

The major causes of deaths in Finland are cardiovascular diseases, malignant tumors, dementia and Alzheimer's disease, respiratory diseases, alcohol related diseases and accidental poisoning by alcohol. In 2010 the leading causes of death among men aged 15 to 64 were alcohol related deaths, ischaemic heart disease, accident, suicides, lung cancer and cerbrovascular diseases. Among women the leading causes were breast cancer, alcohol related deaths, accidents, suicides, ischaemic heart disease and lung cancer.

In 2006, life expectancy for males in Cyprus was 79 and for females 82 years. Infant mortality in 2002 was 5 per 1,000 live births, comparing favourably to most developed nations.

A new measure of expected human capital calculated for 195 countries from 1990 to 2016 and defined for each birth cohort as the expected years lived from age 20 to 64 years and adjusted for educational attainment, learning or education quality, and functional health status was published by The Lancet in September 2018. Estonia had the seventeenth highest level of expected human capital with 24 health, education, and learning-adjusted expected years lived between age 20 and 64 years.

<span class="mw-page-title-main">Health in Iceland</span>

Iceland had the third-lowest crude mortality rate in Europe, at 355 per 100,000 population in 2015. It had the lowest rate of male smokers in Europe: 17%.

<span class="mw-page-title-main">Health in France</span> Overview of health in France

Average life expectancy in France at birth was 81 years in 2008. A new measure of expected human capital calculated for 195 countries from 1990 to 2016 and defined for each birth cohort as the expected years lived from age 20 to 64 years and adjusted for educational attainment, learning or education quality, and functional health status was published by the Lancet in September 2018. France had the ninth highest level of expected human capital with 25 health, education, and learning-adjusted expected years lived between age 20 and 64 years.

<span class="mw-page-title-main">Health in Austria</span> Overview of health in Austria

Legislation on public health issues in Austria is fragmented and in some cases outdated and patchy according to the European Observatory on Health Systems and Policies.

Life expectancy in Andorra was 79.8 for men and 85.2 years for women in 2010.

<span class="mw-page-title-main">Health in Latvia</span> Overview of health in Latvia

A new measure of expected human capital calculated for 195 countries from 1990 to 2016 and defined for each birth cohort as the expected years lived from age 20 to 64 years and adjusted for educational attainment, learning or education quality, and functional health status was published by The Lancet in September 2018. Latvia had the twenty-first highest level of expected human capital with 23 health, education, and learning-adjusted expected years lived between age 20 and 64 years.

<span class="mw-page-title-main">Health in Germany</span> Overview of health in Germany

Germany ranked 20th in the world in life expectancy in 2014 with 76.5 years for men and 82.1 years for women. It had a very low infant mortality rate, and it was eighth place in the number of practicing physicians, at per 1,000 people (3.3).

<span class="mw-page-title-main">Epidemiology of measles</span>

Measles is extremely contagious, but surviving the infection results in lifelong immunity, so its continued circulation in a community depends on the generation of susceptible hosts by birth of children. In communities which generate insufficient new hosts the disease will die out. This concept was first recognized by Bartlett in 1957, who referred to the minimum number supporting measles as the critical community size (CCS). Analysis of outbreaks in island communities suggested that the CCS for measles is c. 250,000. Due to the development of vaccination against measles, the world has seen a 99% decrease in measles related cases compared cases before the vaccine was developed. Unfortunately, the COVID-19 pandemic has created less of a concern of routine measles immunizations, and outbreaks are expected to occur if routine vaccinations of children are not implemented again.

<span class="mw-page-title-main">Health in Luxembourg</span>

A new measure of expected human capital calculated for 195 countries from 1990 to 2016 and defined for each birth cohort as the expected years lived from age 20 to 64 years and adjusted for educational attainment, learning or education quality, and functional health status was published by the Lancet in September 2018. Luxembourg had the eighth highest level of expected human capital with 25 health, education, and learning-adjusted expected years lived between age 20 and 64 years.

References

  1. Lim, Stephen; et, al. "Measuring human capital: a systematic analysis of 195 countries and territories, 1990–2016". Lancet. Retrieved 5 November 2018.
  2. Walkinshaw E (November 2011). "Mandatory vaccinations: The international landscape". CMAJ. 183 (16): E1167-8. doi:10.1503/cmaj.109-3993. PMC   3216445 . PMID   21989473.
  3. Mrvic T, Petrovec M, Breskvar M, Zupanc TL, Logar M (31 March 2012). Mandatory measles vaccination – are healthcare workers really safe?. 22nd European Congress of Clinical Microbiology and Infectious Diseases. London. Archived from the original on 21 October 2013. Retrieved 24 April 2015.
  4. Irena Grmek Kosnik (2012). "Success of the vaccination campaign in Slovenia" (PDF of slidedeck). International Scientific Working Group on Tick-Borne Encephalitis.
  5. Ballas, Dimitris; Dorling, Danny; Hennig, Benjamin (2017). The Human Atlas of Europe. Bristol: Policy Press. p. 66. ISBN   9781447313540.